Related references
Note: Only part of the references are listed.Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission
Per Johan Masse et al.
ANNUAL REVIEW OF MEDICINE (2008)
Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor
Yuxian He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity
Shinya Oishi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Efficient inhibition of the Alzheimer's disease β-secretase by membrane targeting
Lawrence Rajendran et al.
SCIENCE (2008)
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: Importance of fatty acid length, polarity, and bulkiness
Kjeld Madsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Potent D-peptide inhibitors of HIV-1 entry
Brett D. Welch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Christian Wolfrum et al.
NATURE BIOTECHNOLOGY (2007)
Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus
John J. Dwyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
C34, a membrane fusion inhibitor, blocks HIV infection of Langerhans cells and viral transmission to T cells
Makoto Sugaya et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
HIV entry inhibitors targeting gp41: From polypeptides to small-molecule compounds
Shuwen Liu et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody
Micah A. Luftig et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Microbicides and other topical strategies to prevent vaginal transmission of HIV
MM Lederman et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion
RS Veazey et al.
NATURE (2005)
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
MD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection
E Bianchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen
JP Lalezari et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
HIV resistance to the fusion inhibitor enfuvirtide: mechanisms and clinical implications
MD Miller et al.
DRUG RESISTANCE UPDATES (2004)
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV
JJ Eron et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
T Matthews et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
HIV fusion inhibitor peptide T-1249 is able to insert or adsorb to lipidic bilayers. Putative correlation with improved efficiency
AS Veiga et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
HIV-1 gp41 as a target for viral entry inhibition
MJ Root et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The cholesterol membrane anchor of the hedgehog protein confers stable membrane association to lipid-modified proteins
C Peters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
M Egelhofer et al.
JOURNAL OF VIROLOGY (2004)
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection
AG Hovanessian et al.
IMMUNITY (2004)
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5
MM Lederman et al.
SCIENCE (2004)
Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
G Barbato et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
C-terminal octylation rescues an inactive T20 mutant - Implications for the mechanism of HIV/simian immunodeficiency virus-induced membrane fusion
SG Peisajovich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion
JM Louis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
RS Veazey et al.
NATURE MEDICINE (2003)
A monomeric 310-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41
Z Biron et al.
BIOCHEMISTRY (2002)
Antiretroviral-drug resistance among patients recently infected with HIV
SJ Little et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41
CA Bewley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region
DM Eckert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles
DJ Schibli et al.
BIOCHEMISTRY (2001)
Design and properties of NCCG-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity
JM Louis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Membrane-anchored peptide inhibits human immunodeficiency virus entry
M Hildinger et al.
JOURNAL OF VIROLOGY (2001)
Protein design of an HIV-1 entry inhibitor
MJ Root et al.
SCIENCE (2001)
Membrane fusion mediated by coiled coils: A hypothesis
J Bentz
BIOPHYSICAL JOURNAL (2000)
Bioorganic synthesis of lipid-modified proteins for the study of signal transduction
B Bader et al.
NATURE (2000)
Deployment of membrane fusion protein domains during fusion
J Bentz et al.
CELL BIOLOGY INTERNATIONAL (2000)
Share Paper
